Is Real-world Data Latency Holding Back Your Commercial Strategy?
How Japanese pharma leaders are embracing Patient-centric Intelligence
Japanese pharmaceutical leaders are moving beyond data latency concerns to focus on a more crucial question: How can patient data drive commercial success? The answer lies in understanding its strategic value.
